DOI QR코드

DOI QR Code

Stability study of docetaxel solution (0.9%, saline) using Non-PVC and PVC tubes for intravenous administration

  • Park, Kang Hoon (Department of Polymer Science & Engineering, Sungkyunkwan University) ;
  • Chung, Dong June (Department of Polymer Science & Engineering, Sungkyunkwan University)
  • 투고 : 2014.07.15
  • 심사 : 2014.11.28
  • 발행 : 2015.03.31

초록

Background: Di-2-ethylhexyl phthalate (DEHP) are added to poly(vinyl chloride)(PVC) infusion tubes as a plasticizer to ensure tube flexibility. In addition to previously reported disadvantages of DEHP, released DEHP molecules from PVC tubes can easily interact with surfactants in anticancer drug solutions (i.e., polysorbate 80 for Taxotere$^{(R)}$-Inj) and reduce the solubility of docetaxel in aqueous solution during anticancer drug administration. Results: In this study, we investigated the in vitro stability of docetaxel in a 0.9% saline solution under an intravenous administration condition using a PVC tube (high DEHP content) and non-PVC infused tube. Conclusion: The docetaxel solution circulating through the non-PVC tube had better solution stability than through the PVC tube(high DEHP content).

키워드

과제정보

연구 과제 주관 기관 : Ministry of Environment

참고문헌

  1. Hanawa T, Endoh N, Suzuki M, Terada K, Ohkuma M, Sakuta K, et al. Release behavior of diethylhexyl phthalate from the polyvinyl-chloride tubing used for intravenous administration and the plasticized PVC membrane. Internat J Pharm. 2005;297:30-7. https://doi.org/10.1016/j.ijpharm.2005.02.015
  2. Demore' B, Vigneron J, Perrin A, Hoffman MA, Hoffman M. Leaching of diethylhexyl phthalate from polyvinyl chloride bags into intravenous etoposide solution. J Clinical Pharm Therap. 2002;27:139-42. https://doi.org/10.1046/j.1365-2710.2002.00395.x
  3. Joel AT, Ted S, Tee G, Michael MC, Mark R. Health risks posed by use of di-2-ethylhexyl phthalate (DEHP) in PVC medical devices: A critical review. Am J Ind Med. 2001;39:100-11. https://doi.org/10.1002/1097-0274(200101)39:1<100::AID-AJIM10>3.0.CO;2-Q
  4. Koch HM, Preuss R, Angerer J. Di(2-ethylhexyl)phthalate (DEHP): human metabolism and internal exposure - an update and latest results. Int J Androl. 2006;29:155-65. https://doi.org/10.1111/j.1365-2605.2005.00607.x
  5. Anna T, Gerd W, Rainer B, Frank W. Investigation into the sorption of nitroglycerin and diazepam into PVC tubes and alternative tube materials during application. Int J Pharm. 2009;369:30-7. https://doi.org/10.1016/j.ijpharm.2008.10.024
  6. Takehisa H, Emi M, Kohki A, Masahiko S, Mutsuko T, Kenji K, et al. Investigation of the release behavior of diethylhexyl phthalate from the polyvinyl-chloride tubing for intravenous administration. Int J Pharm. 2000;210:109-15. https://doi.org/10.1016/S0378-5173(00)00578-0
  7. Kalra N, Nagpal M, Nyola NK. Sensitive high-performance liquid chromatographic method for the determination of taxol category drug in plasma. Int J Pharm Sci. 2013;2(3-4):65-8.
  8. Yuji H, Fumie S, Tae H, Haruko Y, Chile H, Shunichiro I, et al. Development of a simple method for predicting the levels of di(2-ethylhexyl) phthalate migrated from PVC medical devices into pharmaceutical solutions. Int J Pharm. 2005;298:126-42. https://doi.org/10.1016/j.ijpharm.2005.04.009
  9. Park KH, Park CK, Park J, Jeon SH, Bang SI, Kim JH, et al. Drug adsorption behavior of Polyolefin infusion tube compared to PVC and PU. Polymer (Korea). 2014;38(3):333-7. https://doi.org/10.7317/pk.2014.38.3.333